June 22, 2011

Sanofi Establishes a Global Agreement with Medco and UBC to Improve Quality of Patient Care through Real-World Evidence

- Goal is to better define relative value for products early in development and deliver integrated solutions for patients -

 

Sanofi Establishes a Global Agreement with Medco and UBC to Improve Quality of Patient Care through Real-World Evidence
- Goal is to better define relative value for products early in development and deliver integrated solutions for patients -

Paris, France – June 22, 2011 – Sanofi (EURONEXT: SAN and NYSE: SNY) announced today that it has entered into a global agreement with Medco Health Solutions, Inc. (NYSE: MHS) (Medco), and United BioSource Corporation (UBC), a wholly owned subsidiary of Medco, to better leverage the real-world evidence generated during product development and throughout the product lifecycle in order to improve the overall quality of patient care.